General

Rossari Biotech reports Q3 FY26 consolidated profit at Rs. 32.77 Cr

The company has posted net profit of Rs. 103.24 crore for the 9 months period ended December 31, 2025

  • By ICN Bureau | January 18, 2026

Rossari Biotech Limited has reported consolidated financial results for the period ended December 31, 2025.

Rossari Biotech has posted net profit of Rs. 32.77 crore for the period ended December 31, 2025 as against net profit of Rs. 36.87 crore for the period ended September 30, 2025. The company has posted net profit of Rs. 31.70 crore for the period ended December 31, 2024.

Rossari Biotech has reported total income of Rs. 582.18 crore during the period ended December 31, 2025 as compared to Rs. 587.71 crore during the period ended September 30, 2025. The company reported total income of Rs. 513.28 crore during the period ended December 31, 2024.

For the 9 months period ended December 31, 2025, Rossari Biotech has reported total income of Rs. 1,714.81 crore as compared to Rs. 1,502.95 crore during the 9 months period ended December 31, 2024.

The company has posted net profit of Rs. 103.24 crore for the 9 months period ended December 31, 2025 as against net profit of Rs. 101.93 crore for the 9 months period ended December 31, 2024.

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization